{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:38:30Z","timestamp":1788305910254,"version":"build-2803163510"},"reference-count":187,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.beem.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T04:03:06Z","timestamp":1527480186000},"page":"639-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Hypocalcemic disorders"],"prefix":"10.1016","volume":"32","author":[{"given":"Erin","family":"Bove-Fenderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.05.006_bib1","series-title":"Clinical methods: the history, physical, and laboratory examinations","article-title":"Serum calcium","author":"Goldstein","year":"1990"},{"key":"10.1016\/j.beem.2018.05.006_bib2","series-title":"Chapter 4-interactions of PTH with receptors and signaling A2-bilezikian, John P. The parathyroids","first-page":"65","author":"Gardella","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib3","series-title":"Chapter 6-control of parathyroid hormone secretion by its key physiological regulators A2-bilezikian, John P. The parathyroids","first-page":"101","author":"Brown","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/me.2006-0110","article-title":"Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor","volume":"21","author":"Wettschureck","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2018.05.006_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ceca.2003.10.017","article-title":"Calcium receptor-mediated intracellular signalling","volume":"35","author":"Ward","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.beem.2018.05.006_bib6","series-title":"Chapter 2-parathyroid hormone gene: structure, evolution, and regulation A2-bilezikian, John P. The parathyroids","first-page":"37","author":"Mannstadt","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ecl.2010.02.007","article-title":"The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3)","volume":"39","author":"Pike","year":"2010","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.1016\/j.beem.2018.05.006_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/bonekey.2013.230","article-title":"Vitamin D endocrine system and the intestine","volume":"3","author":"Christakos","year":"2014","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.beem.2018.05.006_bib9","series-title":"Endotext","article-title":"Calcium and phosphate homeostasis","author":"Shaker","year":"2000"},{"key":"10.1016\/j.beem.2018.05.006_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(97)12331-5","article-title":"Electrolyte quintet: calcium","volume":"352","author":"Bushinsky","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.05.006_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jcp.32.1.56","article-title":"Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual","volume":"32","author":"Payne","year":"1979","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.beem.2018.05.006_bib13","doi-asserted-by":"crossref","first-page":"f2213","DOI":"10.1136\/bmj.f2213","article-title":"Investigating hypocalcaemia","volume":"346","author":"Hannan","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.beem.2018.05.006_bib14","series-title":"Chapter 47-hypoparathyroidism in the differential diagnosis of hypocalcemia A2-bilezikian, John P. The parathyroids","first-page":"687","author":"Shoback","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib15","series-title":"Endotext","article-title":"Hypocalcemia: diagnosis and treatment","author":"Schafer","year":"2000"},{"key":"10.1016\/j.beem.2018.05.006_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1378\/chest.119.2.668-a","article-title":"ECG abnormalities associated with hypocalcemia","volume":"119","author":"Ru Dusky","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.beem.2018.05.006_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-203512","article-title":"A\u00a0surprising cause of reversible dilated cardiomyopathy","volume":"2014","author":"Vlot","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.beem.2018.05.006_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1515\/jpem-2012-0201","article-title":"Autoimmune polyglandular syndrome type 1 with reversible dilated cardiomyopathy: complete recovery after correction of hypocalcemia and hypocortisolemia","volume":"26","author":"Wani","year":"2013","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib19","first-page":"43","article-title":"Signs of hypocalcemia: Chvostek's and Trousseau's signs","volume":"36","author":"Urbano","year":"2000","journal-title":"Hosp Physician"},{"key":"10.1016\/j.beem.2018.05.006_bib20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bmj.39582.589433.BE","article-title":"Diagnosis and management of hypocalcaemia","volume":"336","author":"Cooper","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.beem.2018.05.006_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijsu.2016.08.019","article-title":"Predictors and risk factors of hypoparathyroidism after total thyroidectomy","volume":"34","author":"Cho","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.beem.2018.05.006_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/EJE-17-0589","article-title":"Time to parathyroid function recovery in patients with protracted hypoparathyroidism after total thyroidectomy","volume":"178","author":"Villarroya-Marquina","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.05.006_bib23","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","article-title":"Prevalence and incidence of hypoparathyroidism in the United States using a large claims database","volume":"28","author":"Powers","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib24","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib25","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1038\/nrdp.2017.80","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.beem.2018.05.006_bib26","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.21037\/gs.2017.09.03","article-title":"Incidence, prevalence and risk factors for post-surgical hypocalcaemia and hypoparathyroidism","volume":"6","author":"Edafe","year":"2017","journal-title":"Gland Surg"},{"key":"10.1016\/j.beem.2018.05.006_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MOO.0000000000000346","article-title":"Hypoparathyroidism after thyroidectomy: prevention, assessment and management","volume":"25","author":"Dedivitis","year":"2017","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.beem.2018.05.006_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jamcollsurg.2016.04.049","article-title":"Cutting edge in thyroid surgery: autofluorescence of parathyroid glands","volume":"223","author":"Falco","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.beem.2018.05.006_bib29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jso.24583","article-title":"The use of near-infrared fluorescence imaging in endocrine surgical procedures","volume":"115","author":"Kahramangil","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.beem.2018.05.006_bib30","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.21037\/gs.2017.09.15","article-title":"Short and long-term impact of parathyroid autotransplantation on parathyroid function after total thyroidectomy","volume":"6","author":"Hicks","year":"2017","journal-title":"Gland Surg"},{"key":"10.1016\/j.beem.2018.05.006_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","article-title":"An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains","volume":"17","author":"Aaltonen","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrendo.2010.200","article-title":"The role of AIRE in human autoimmune disease","volume":"7","author":"Akirav","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2018.05.006_bib34","series-title":"Chapter 50-the molecular genetics of hypoparathyroidism A2-bilezikian, John P. The parathyroids","first-page":"719","author":"Cianferotti","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI114811","article-title":"Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism","volume":"86","author":"Arnold","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.006_bib36","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/jc.2017-00250","article-title":"Autosomal dominant PTH gene signal sequence mutation in a family with familial isolated hypoparathyroidism","volume":"102","author":"Cinque","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib37","first-page":"3792","article-title":"A\u00a0novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism","volume":"84","author":"Sunthornthepvarakul","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib38","doi-asserted-by":"crossref","first-page":"19989","DOI":"10.1073\/pnas.0708725104","article-title":"Signal sequence mutation in autosomal dominant form of hypoparathyroidism induces apoptosis that is corrected by a chemical chaperone","volume":"104","author":"Datta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.05.006_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ng0592-149","article-title":"A\u00a0donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism","volume":"1","author":"Parkinson","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bone.2012.06.009","article-title":"A\u00a0novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism","volume":"51","author":"Ertl","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.05.006_bib41","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI200113180","article-title":"Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB","volume":"108","author":"Ding","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.006_bib42","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1210\/jc.2004-2450","article-title":"GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone","volume":"90","author":"Thom\u00e9e","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.2004.026898","article-title":"Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism","volume":"42","author":"Baumber","year":"2005","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib44","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1210\/jc.2007-2167","article-title":"Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism","volume":"93","author":"Mannstadt","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib45","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1210\/jc.2009-2532","article-title":"A\u00a0missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism","volume":"95","author":"Mirczuk","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib46","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1172\/JCI24156","article-title":"An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism","volume":"115","author":"Bowl","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.006_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2016.00458","article-title":"Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2","volume":"7","author":"Roszko","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.beem.2018.05.006_bib48","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.87.3.1309","article-title":"Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia","volume":"87","author":"D'Souza-Li","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fphys.2016.00441","article-title":"Molecular basis of the extracellular ligands mediated signaling by the calcium sensing receptor","volume":"7","author":"Zhang","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.beem.2018.05.006_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13662","article-title":"Structural mechanism of ligand activation in human calcium-sensing receptor","volume":"5","author":"Geng","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.beem.2018.05.006_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.14310\/horm.2002.1734","article-title":"Clinical characterization of a novel calcium sensing receptor genetic alteration in a Greek patient with autosomal dominant hypocalcemia type 1","volume":"16","author":"Papadopoulou","year":"2017","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.beem.2018.05.006_bib52","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2265.2011.04142.x","article-title":"Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey","volume":"75","author":"Raue","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.05.006_bib53","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1210\/jcem.86.11.8016","article-title":"Activating mutations of the calcium-sensing receptor: management of hypocalcemia","volume":"86","author":"Lienhardt","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib54","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A\u00a0familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib55","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jcem.87.7.8639","article-title":"Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene","volume":"87","author":"Sato","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib56","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1210\/jc.2013-3430","article-title":"Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia","volume":"99","author":"Kinoshita","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2018.05.006_bib58","first-page":"3480","article-title":"A\u00a0randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib59","doi-asserted-by":"crossref","first-page":"E229","DOI":"10.1210\/jc.2010-0651","article-title":"Novel activating mutations of the calcium-sensing receptor: the calcilytic NPS-2143 mitigates excessive signal transduction of mutant receptors","volume":"95","author":"Letz","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bone.2013.05.021","article-title":"Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women","volume":"56","author":"Caltabiano","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.05.006_bib61","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.metabol.2015.07.011","article-title":"Novel therapies for osteoporosis","volume":"64","author":"Makras","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2018.05.006_bib62","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/en.2015-1269","article-title":"The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing receptor (CaSR) mutation: relevance to autosomal dominant hypocalcemia type 1 (ADH1)","volume":"156","author":"Hannan","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.05.006_bib63","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jbmr.2551","article-title":"Calcilytic ameliorates abnormalities of mutant calcium-sensing receptor (CaSR) knock-in mice mimicking autosomal dominant hypocalcemia (ADH)","volume":"30","author":"Dong","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib64","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/jbmr.2763","article-title":"Treatment of autosomal dominant hypocalcemia with the calcilytic NPSP795. 2015 Annual Meeting of the American Society for Bone and Mineral Research Seattle, WA October 9\u201312, 2015","volume":"30","author":"Ramnitz","year":"2015","journal-title":"J\u00a0Bone Min Res"},{"key":"10.1016\/j.beem.2018.05.006_bib65","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib66","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib67","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1056\/NEJMc1300278","article-title":"Germline mutations affecting Galpha11 in hypoparathyroidism","volume":"368","author":"Mannstadt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib68","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jbmr.2797","article-title":"Identification of a g-protein subunit-alpha11 gain-of-function mutation, Val340Met, in a family with autosomal dominant hypocalcemia type 2 (ADH2)","volume":"31","author":"Piret","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EJE-16-0109","article-title":"Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation","volume":"175","author":"Tenhola","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.05.006_bib70","doi-asserted-by":"crossref","first-page":"e91103","DOI":"10.1172\/jci.insight.91103","article-title":"Galpha11 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy","volume":"2","author":"Gorvin","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.beem.2018.05.006_bib71","doi-asserted-by":"crossref","first-page":"e91079","DOI":"10.1172\/jci.insight.91079","article-title":"Knockin mouse with mutant Galpha11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors","volume":"2","author":"Roszko","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.beem.2018.05.006_bib72","doi-asserted-by":"crossref","first-page":"10876","DOI":"10.1074\/jbc.M115.696401","article-title":"Allosteric modulation of the calcium-sensing receptor rectifies signaling abnormalities associated with g-protein alpha-11 mutations causing hypercalcemic and hypocalcemic disorders","volume":"291","author":"Babinsky","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.05.006_bib73","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 deletion syndrome","volume":"1","author":"McDonald-McGinn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.beem.2018.05.006_bib74","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(03)14632-6","article-title":"Role of TBX1 in human del22q11.2 syndrome","volume":"362","author":"Yagi","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.05.006_bib75","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/35019088","article-title":"GATA3 haplo-insufficiency causes human HDR syndrome","volume":"406","author":"Van Esch","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.beem.2018.05.006_bib76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archpedi.1966.02090050133013","article-title":"Dwarfism and cortical thickening of tubular bones. Transient hypocalcemia in a mother and son","volume":"111","author":"Kenny","year":"1966","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.beem.2018.05.006_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2214\/ajr.100.1.1","article-title":"Congenital stenosis of medullary spaces in tubular bones and Calvaria in two proportionate dwarfs\u2014mother and son; coupled with transitory hypocalcemic tetany","volume":"100","author":"Caffey","year":"1967","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.beem.2018.05.006_bib78","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng1012","article-title":"The HRDARKCSC. Mutation of TBCE causes hypoparathyroidism\u2013retardation\u2013dysmorphism and autosomal recessive Kenny\u2013Caffey syndrome","volume":"32","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib79","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jbmr.2091","article-title":"A\u00a0recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2","volume":"29","author":"Isojima","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib80","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/archinte.1984.00350210112019","article-title":"Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia","volume":"144","author":"Whang","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2018.05.006_bib81","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism: present and future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib82","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.beem.2018.05.006_bib83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.beem.2018.05.006_bib84","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gft400","article-title":"Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration","volume":"29","author":"Rodriguez-Ortiz","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.beem.2018.05.006_bib85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0026-0495(84)90131-8","article-title":"Extracellular calcium potentiates the inhibitory effects of magnesium on parathyroid function in dispersed bovine parathyroid cells","volume":"33","author":"Brown","year":"1984","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2018.05.006_bib86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/089686089901900509","article-title":"Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients","volume":"19","author":"Navarro","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.beem.2018.05.006_bib87","first-page":"1","article-title":"Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy","volume":"3","author":"McGonigle","year":"1984","journal-title":"Magnesium"},{"key":"10.1016\/j.beem.2018.05.006_bib88","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM198405103101904","article-title":"The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects","volume":"310","author":"Cholst","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib89","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.ajog.2004.02.050","article-title":"Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine","volume":"190","author":"Koontz","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2018.05.006_bib90","series-title":"Chapter 48-magnesium depletion and parathyroid function A2-bilezikian, John P. The parathyroids","first-page":"697","author":"Klein","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib91","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00467-016-3416-3","article-title":"Genetic causes of hypomagnesemia, a clinical overview","volume":"32","author":"Viering","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.beem.2018.05.006_bib92","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.1976.tb01947.x","article-title":"Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency","volume":"5","author":"Rude","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.05.006_bib93","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.177.4049.606","article-title":"Evidence for parathyroid failure in magnesium deficiency","volume":"177","author":"Anast","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.beem.2018.05.006_bib94","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1074\/jbc.M007727200","article-title":"Paradoxical block of parathormone secretion is mediated by increased activity of G alpha subunits","volume":"276","author":"Quitterer","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"Suppl. 4","key":"10.1016\/j.beem.2018.05.006_bib95","doi-asserted-by":"crossref","first-page":"iv63","DOI":"10.1093\/ndt\/gfu198","article-title":"Inherited disorders of renal hypomagnesaemia","volume":"29","author":"Konrad","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.beem.2018.05.006_bib96","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10157-008-0126-6","article-title":"Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: unusual clinical associations and novel claudin16 mutation in an Egyptian family","volume":"13","author":"Al-Haggar","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.beem.2018.05.006_bib97","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00223-014-9951-7","article-title":"First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family","volume":"96","author":"Yuan","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.05.006_bib98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12882-015-0079-4","article-title":"Identification of the first large deletion in the CLDN16 gene in a patient with FHHNC and late-onset of chronic kidney disease: case report","volume":"16","author":"Yamaguti","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.beem.2018.05.006_bib99","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2369-9-12","article-title":"Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene","volume":"9","author":"Hampson","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.beem.2018.05.006_bib100","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1681\/ASN.V1291872","article-title":"Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis","volume":"12","author":"Weber","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.beem.2018.05.006_bib101","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng901","article-title":"Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia","volume":"31","author":"Walder","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib102","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng889","article-title":"Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family","volume":"31","author":"Schlingmann","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib103","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1681\/ASN.2004110989","article-title":"Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia","volume":"16","author":"Schlingmann","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.beem.2018.05.006_bib104","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib105","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib106","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib107","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.05.006_bib108","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.05.006_bib109","first-page":"251","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study","volume":"36","author":"Clarke","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.beem.2018.05.006_bib111","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1172\/JCI109954","article-title":"New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease","volume":"66","author":"Price","year":"1980","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.006_bib112","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00441552","article-title":"Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment","volume":"148","author":"Kruse","year":"1989","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beem.2018.05.006_bib113","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001980200009","article-title":"Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone","volume":"13","author":"Minisola","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.05.006_bib114","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00198-016-3750-0","article-title":"Bone imaging in hypoparathyroidism","volume":"28","author":"Silva","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.05.006_bib116","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1210\/jc.2002-021388","article-title":"Increased bone mineral density in patients with chronic hypoparathyroidism","volume":"88","author":"Chan","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib117","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2006.02479.x","article-title":"Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism","volume":"64","author":"Laway","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.beem.2018.05.006_bib118","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jbmr.3328","article-title":"Bone status among patients with nonsurgical hypoparathyroidism, autosomal dominant hypocalcaemia, and pseudohypoparathyroidism: a cohort study","volume":"33","author":"Underbjerg","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib119","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.2609","article-title":"Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism","volume":"31","author":"Cusano","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.05.006_bib121","first-page":"2135","article-title":"Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism","volume":"80","author":"Fujiyama","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib122","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1007\/s00268-013-2207-2","article-title":"Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy","volume":"37","author":"Takamura","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2018.05.006_bib123","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2013risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib124","series-title":"Chapter 56-treatment of hypoparathyroidism with calcium and vitamin D A2-bilezikian, John P. The parathyroids","first-page":"807","author":"Rahman","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM197803162981101","article-title":"Treatment of hypoparathyroid patients with chlorthalidone","volume":"298","author":"Porter","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib126","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031237","article-title":"Regulation of bone remodeling by parathyroid hormone","author":"Wein","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.beem.2018.05.006_bib127","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism: results of a short-term randomized crossover trial","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2018.05.006_bib128","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid Hormone-(1\u201334) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib129","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17446651.2015.971755","article-title":"PTH(1-84) replacement therapy for the treatment of hypoparathyroidism","volume":"10","author":"Cusano","year":"2015","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib131","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/jc.2015-4135","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective six year investigation of efficacy and safety","volume":"101","author":"Rubin","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib132","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib133","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2018.05.006_bib134","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2017-01471","article-title":"Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism","volume":"103","author":"Vokes","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib136","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib137","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jbmr.2777","article-title":"Effects of parathyroid hormone administration on bone strength in hypoparathyroidism","volume":"31","author":"Rubin","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.05.006_bib138","first-page":"922","article-title":"Pseudo-hypoparathyroidism\u2013an example of 'Seabright-Bantam syndrome': report of three cases","volume":"30","author":"Albright","year":"1942","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.05.006_bib139","series-title":"Chapter 55-molecular and clinical Aspects of pseudohypoparathyroidism A2-bilezikian, John P. The parathyroids","first-page":"781","author":"Levine","year":"2015"},{"key":"10.1016\/j.beem.2018.05.006_bib140","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1172\/JCI106149","article-title":"Pseudohypoparathyroidism: defective excretion of 3\u2032,5\u2032-AMP in response to parathyroid hormone","volume":"48","author":"Chase","year":"1969","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.006_bib141","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/8756-3282(93)90204-N","article-title":"The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism","volume":"14","author":"Stone","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.05.006_bib142","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00444941","article-title":"A\u00a0simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone","volume":"146","author":"Kruse","year":"1987","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beem.2018.05.006_bib143","first-page":"65","article-title":"GNAS locus and pseudohypoparathyroidism","volume":"63","author":"Bastepe","year":"2005","journal-title":"Horm Res."},{"key":"10.1016\/j.beem.2018.05.006_bib144","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.22696","article-title":"GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders","volume":"36","author":"Lemos","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.05.006_bib145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/humu.22265","article-title":"Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations","volume":"34","author":"Elli","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.05.006_bib146","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1203\/01.PDR.0000059752.07086.A2","article-title":"Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism","volume":"53","author":"De Sanctis","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1016\/j.beem.2018.05.006_bib147","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-8628(19980526)77:4<261::AID-AJMG2>3.0.CO;2-Q","article-title":"Pseudohypoparathyroidism type Ia from maternal but not paternal transmission of a Gsalpha gene mutation","volume":"77","author":"Nakamoto","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-0-387-77576-0_3","article-title":"The GNAS locus and pseudohypoparathyroidism","volume":"626","author":"Bastepe","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.beem.2018.05.006_bib149","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/429932","article-title":"A\u00a0novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS","volume":"76","author":"Linglart","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib150","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2011-2804","article-title":"A\u00a0new deletion ablating NESP55 causes loss of maternal imprint of A\/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib","volume":"97","author":"Richard","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib151","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214673","article-title":"Pseudohypoparathyroidism type 1B caused by methylation changes at the GNAS complex locus","volume":"2016","author":"Poradosu","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.beem.2018.05.006_bib152","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.1320110104","article-title":"Albright's hereditary osteodystrophy: a review","volume":"11","author":"Fitch","year":"1982","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.beem.2018.05.006_bib153","first-page":"337","article-title":"Pseudo-pseudohypoparathyroidism","volume":"65","author":"Albright","year":"1952","journal-title":"Trans Assoc Am Phys"},{"key":"10.1016\/j.beem.2018.05.006_bib154","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02555000","article-title":"Heterogeneity of pseudohypoparathyroidism type I from the aspect of urinary excretion of calcium and serum levels of parathyroid hormone","volume":"46","author":"Mizunashi","year":"1990","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2018.05.006_bib155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib156","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","article-title":"Current understanding of the molecular actions of vitamin D","volume":"78","author":"Jones","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.beem.2018.05.006_bib157","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.beem.2011.05.003","article-title":"Regulation of vitamin D metabolism","volume":"25","author":"Henry","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.05.006_bib158","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","article-title":"Prevalence and correlates of vitamin D deficiency in US adults","volume":"31","author":"Forrest","year":"2011","journal-title":"Nutr Res"},{"key":"10.1016\/j.beem.2018.05.006_bib159","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM197211022871803","article-title":"Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults","volume":"287","author":"Hahn","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.56.1.45","article-title":"Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children","volume":"56","author":"Tolman","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2018.05.006_bib161","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0884533612467824","article-title":"Drug-vitamin D interactions: a systematic review of the literature","volume":"28","author":"Robien","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.beem.2018.05.006_bib162","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2012-1711","article-title":"Prevalence of vitamin D deficiency among overweight and obese US children","volume":"131","author":"Turer","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2018.05.006_bib163","doi-asserted-by":"crossref","first-page":"868961","DOI":"10.1155\/2015\/868961","article-title":"Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease","volume":"2015","author":"Obi","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.beem.2018.05.006_bib164","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2014.19","article-title":"Vitamin D\/dietary calcium deficiency rickets and pseudo-vitamin D deficiency rickets","volume":"3","author":"Glorieux","year":"2014","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.beem.2018.05.006_bib165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/archdischild-2011-301264","article-title":"Vitamin D and child health part 1 (skeletal aspects)","volume":"98","author":"Shaw","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.beem.2018.05.006_bib166","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","article-title":"Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes","volume":"102","author":"Sabbagh","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.05.006_bib167","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0002-9343(99)00460-X","article-title":"Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption","volume":"108","author":"Basha","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib168","doi-asserted-by":"crossref","first-page":"966","DOI":"10.7326\/0003-4819-89-6-966","article-title":"Osteomalacia: current concepts","volume":"89","author":"Frame","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.05.006_bib169","first-page":"E8","article-title":"Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition","volume":"53","author":"McCollum","year":"1922","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.05.006_bib170","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(80)90283-4","article-title":"Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol","volume":"2","author":"Papapoulos","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.05.006_bib171","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1210\/jc.2006-2664","article-title":"Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency","volume":"92","author":"Kim","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib172","first-page":"1961","article-title":"Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1","volume":"11","author":"Fu","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2018.05.006_bib173","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1056\/NEJM197811022991803","article-title":"Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease","volume":"299","author":"Scriver","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib174","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3476(81)80952-3","article-title":"Vitamin D dependency: replacement therapy with calcitriol?","volume":"99","author":"Delvin","year":"1981","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2018.05.006_bib175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2010.02.004","article-title":"Genetic disorders and defects in vitamin d action","volume":"39","author":"Malloy","year":"2010","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.1016\/j.beem.2018.05.006_bib176","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2014.5","article-title":"Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets","volume":"3","author":"Feldman","year":"2014","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.beem.2018.05.006_bib177","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jcem-55-5-1020","article-title":"Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3","volume":"55","author":"Feldman","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.05.006_bib178","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI114944","article-title":"The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families","volume":"86","author":"Malloy","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.05.006_bib179","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-3476(05)81919-5","article-title":"Calcium therapy for calcitriol-resistant rickets","volume":"121","author":"Hochberg","year":"1992","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2018.05.006_bib180","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00198-015-3076-3","article-title":"Normal bone mass and normocalcemia in adulthood despite homozygous vitamin D receptor mutations","volume":"26","author":"Damiani","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2018.05.006_bib181","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2169\/internalmedicine.8618-16","article-title":"Management of osteoporosis in chronic kidney disease","volume":"56","author":"Nitta","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.beem.2018.05.006_bib182","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000380960","article-title":"Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5","volume":"41","author":"Dave","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.beem.2018.05.006_bib183","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ajco.12517","article-title":"Denosumab: prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures","volume":"13","author":"Pittman","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.beem.2018.05.006_bib184","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0272-6386(01)80116-5","article-title":"Hypocalcemia: a pervasive metabolic abnormality in the critically ill","volume":"37","author":"Zivin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2018.05.006_bib185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(88)90415-9","article-title":"Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting","volume":"84","author":"Desai","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.05.006_bib186","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-107-1-36","article-title":"The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone-vitamin D axis","volume":"107","author":"Zaloga","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.05.006_bib187","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1097\/CCM.0b013e3181dda0be","article-title":"Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit","volume":"38","author":"Buckley","year":"2010","journal-title":"Crit Care Med"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:52:44Z","timestamp":1761497564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18300745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":187,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1521690X18300745"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.05.006","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypocalcemic disorders","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}